DETALII
Citeste mai mult
Descriere RO
This book focuses on current research and methodologies developed for re-engineering cancer clinical trials and also for "hot" areas in drug development trials such as adaptive design, seamless Phase 2-3 trials, and personalized medicine using biomarkers. Background statistical methodology is summarized in the Appendix.
EdituraTaylor & Francis Inc
Dimensiuni234 x 156
Data Publicarii15/01/2026
FormatCartonata
Numar pagini300
Aceasta este o carte in limba engleza. Descrierea cartii (tradusa din engleza cu Google Translate) este in limba romana din motive legale.